SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001615219-18-000040
Filing Date
2018-06-20
Accepted
2018-06-20 16:16:34
Documents
1
Period of Report
2018-06-08
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A a8-kacorporateupdate.htm 8-K/A 29765
  Complete submission text file 0001615219-18-000040.txt   31010
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36812 | Film No.: 18909563
SIC: 2834 Pharmaceutical Preparations